Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide. 1990

B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
Institut Henri Beaufour, France.

Interleukin-1 (IL-1) is a member of a family of closely related molecules playing an important role in many inflammatory and immunologic reactions. Besides macrophages, epidermal cells such as keratinocytes release, either spontaneously or on stimulation, IL-1-like molecules also referred to as epidermal cell-derived thymocyte-activating factor (ETAF). In the present study, the potential role of the potent lipid mediator, platelet-activating factor (PAF), in the regulation of IL-1/ETAF release by keratinocytes was investigated. Keratinocytes from guinea-pig ears were incubated for 24 h in the presence or absence of lipopolysaccharide (LPS) and PAF, either alone or in combination. LPS markedly increased in a dose-dependent fashion the IL-1/ETAF release by keratinocytes, as assessed by the mouse thymocyte proliferation assay. In contrast, no effect of PAF on IL-1/ETAF release was observed. Simultaneous addition of 1 microgram/ml LPS and 1 pM PAF to keratinocyte culture increased IL-1/ETAF release compared to that observed with LPS alone. When 1 pM PAF was added 1 h before or 1 h after LPS, no effect on IL-1/ETAF release by keratinocytes was noted. In contrast, regardless of the time of addition of 10 fM PAF to keratinocytes stimulated with LPS (either simultaneously or 1 h after LPS), an identical and non-significant increase was observed. In conclusion, although PAF is not able to induce IL-1/ETAF release by keratinocytes, it potentiates that induced by a stimulus like endotoxin.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001381 Azepines Seven membered heterocyclic rings containing a NITROGEN atom. Hexamethyleneimines
D015603 Keratinocytes Epidermal cells which synthesize keratin and undergo characteristic changes as they move upward from the basal layers of the epidermis to the cornified (horny) layer of the skin. Successive stages of differentiation of the keratinocytes forming the epidermal layers are basal cell, spinous or prickle cell, and the granular cell. Keratinocyte

Related Publications

B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
May 1982, Journal of immunology (Baltimore, Md. : 1950),
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
January 1986, Annales de dermatologie et de venereologie,
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
January 1984, Microbiology and immunology,
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
May 1988, Fukuoka igaku zasshi = Hukuoka acta medica,
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
December 1986, The Journal of experimental medicine,
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
October 1981, Journal of immunology (Baltimore, Md. : 1950),
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
August 1989, The Journal of investigative dermatology,
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
October 1985, The Journal of clinical investigation,
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
January 1988, Archives of dermatological research,
B Pignol, and M O Lonchampt, and P E Chabrier, and J M Mencia-Huerta, and P Braquet
March 1988, Clinical immunology and immunopathology,
Copied contents to your clipboard!